The demand for cannabis continues to increase across Europe

While in the USA and Canada cannabis for adults is legal in specialist shops, people in the EU continue to be persecuted for the use of cannabis. What influence does the corona crisis have on cannabis demand in Europe?

Although cannabis is now available on prescription in some states of the European Union, overall drug policies have not changed much in terms of repression and injustice. Now there is also data on trends in consumption, in growing cannabis, and on the profitability of the cannabis industry. All policymakers in Brussels or even Berlin cannot stop the popularity of hashish and cannabis, now that people in Europe prefer smoking cannabis over drinking a beer.

If you want to find the latest cannabis news in the world and to read more about the cannabis and hemp industries, download for free teh Hemp.im mobile app.

Do lockdown and quarantine have any influence on cannabis in the EU?

Hardly. A look at the data shows a constantly increasing, strong demand for cannabis-based products. More than 40 million Europeans use cannabis in one form or another – that’s a good 6% of the population.

The black market is flourishing due to ignorant legislation. All prohibitions and brutal raids do not bring a decrease in consumption, on the contrary! The dull insistence, especially in Germany, leads to a total failure of drug policy in terms of prevention and education. That is because people want to consume cannabis, especially during the pandemic. 

A look at the cannabis production in Europe

The Netherlands remains a hotspot for cannabis cultivation, with a lot of cannabis from North Africa coming into the EU in the form of hashish. Albania cultivates a lot of cannabis and, in addition, indoor self-cultivation with a lamp at home often ends up on the market, so there are no supply problems. 

The legal cannabis producers, who extract for example high-quality cannabis oil with the sought-after cannabinoids, use techniques borrowed from overseas. A lot of consumers pay attention explicitly to the manufacturing process, they want information about the bottling and the used plant material.

Will the coronavirus pandemic lead to the legalization of cannabis?

This is the point researchers make in their current studies of data from Europe: the existing drug policy of prohibition has failed, even if this realization has not yet penetrated the glass palaces of political bosses. In order to satisfy the enormous demand for a stimulant alternative to beer and spirits in a thoughtful manner, EU policy should no longer punish cannabis consumption. It should finally respect citizens and not the least adult taxpayers.

In recent surveys, people indicated that they would rather smoke cannabis in the event of a lockdown than drink. One may well ask what legitimacy is there for continuing to ignore the needs of more than 40 million people in Europe? Especially when these citizens are supposed to pay for the big shots in Brussels and Strasbourg?

__

(Featured image by djriel via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in THC.GUIDE, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.